Therapeutic Inhibition of Prolyl Hydroxylase Domain-containing Enzymes in Surgery: Putative Applications and Challenges
Overview
Authors
Affiliations
Oxygen is essential for metazoans to generate energy. Upon oxygen deprivation adaptive and protective pathways are induced, mediated by hypoxia-inducible factors (HIFs) and prolyl hydroxylase domain-containing enzymes (PHDs). Both play a pivotal role in various conditions associated with prolonged ischemia and inflammation, and are promising targets for therapeutic intervention. This review focuses on aspects of therapeutic PHD modulation in surgically relevant disease conditions such as hepatic and intestinal disorders, wound healing, innate immune responses, and tumorigenesis, and discusses the therapeutic potential and challenges of PHD inhibition in surgical patients.
The HIF-prolyl hydroxylases have distinct and nonredundant roles in colitis-associated cancer.
Kennel K, Burmeister J, Radhakrishnan P, Giese N, Giese T, Salfenmoser M JCI Insight. 2022; 7(22).
PMID: 36509284 PMC: 9746807. DOI: 10.1172/jci.insight.153337.
Iacob A, Dragan M, Ionescu O, Profire L, Ficai A, Andronescu E Pharmaceutics. 2020; 12(10).
PMID: 33080849 PMC: 7589858. DOI: 10.3390/pharmaceutics12100983.
Dirscherl K, Schlapfer M, Roth Zgraggen B, Wenger R, Booy C, Flury-Frei R Sci Rep. 2020; 10(1):4392.
PMID: 32152325 PMC: 7062856. DOI: 10.1038/s41598-020-60709-9.
Erber L, Luo A, Chen Y Mol Cell Proteomics. 2019; 18(9):1772-1781.
PMID: 31239290 PMC: 6731074. DOI: 10.1074/mcp.RA119.001535.
Prolyl Hydroxylase Domain-2 Protein Regulates Lipopolysaccharide-Induced Vascular Inflammation.
Fan Q, Mao H, Xie L, Pi X Am J Pathol. 2018; 189(1):200-213.
PMID: 30339838 PMC: 6315327. DOI: 10.1016/j.ajpath.2018.09.012.